Review
Open access
Aug 2026
Neoantigen cancer vaccines in the mRNA Era: antigen selection, platform engineering, and clinical translation.
The strongest current signal supports use in adjuvant, perioperative, and minimal residual disease settings, usually in combination with checkpoint blockade or other immune-modifying strategies, usually in combination with checkpoint blockade or other immune-modifying strategies.
Minglu Ge, Ning Wu
· Cancer Treatment and Researc... · 0 citations